Shire, Takeda Shareholders Give All Clear To £46B Deal
Shareholders in Takeda Pharmaceuticals on Wednesday gave their seal of approval to the proposed £46 billion ($59 billion) acquisition of Shire PLC, paving the way for the deal's completion after investors...To view the full article, register now.
Already a subscriber? Click here to view full article